Zhang J, et al. Discovery of a novel Nrf2 inhibitor that induces apoptosis of human acute myeloid leukemia cells, (in eng). Oncotarget. 2017;8(5):7625–36. https://doi.org/10.18632/oncotarget.13825.

Article  PubMed  Google Scholar 

Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Rev. 2019;36:70–87. https://doi.org/10.1016/j.blre.2019.04.005.

Article  PubMed  Google Scholar 

Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023. https://doi.org/10.1186/s13045-023-01424-6.

Article  PubMed  PubMed Central  Google Scholar 

He F, Ru X, Wen T. NRF2, a transcription factor for stress response and beyond. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21134777.

Article  PubMed  PubMed Central  Google Scholar 

Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 2020. https://doi.org/10.3390/molecules25225474.

Article  PubMed  PubMed Central  Google Scholar 

Juan CA, Pérez de la Lastra JM, Plou FJ, Pérez-Lebeña E. The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. Int J Mol Sci. 2021;22(9):4642. 10.3390/ijms22094642

Article  PubMed  PubMed Central  Google Scholar 

Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes, (in eng). Trends Biochem Sci. 2010;35(9):505–13. https://doi.org/10.1016/j.tibs.2010.04.002.

Article  PubMed  PubMed Central  Google Scholar 

Liu X, et al. Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis. Exp Hematol Oncol. 2023;12(1):47.https://doi.org/10.1186/s40164-023-00411-4

Article  PubMed  PubMed Central  Google Scholar 

Totoki Y, et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes, (in eng). Nat Genet. 2014;46(12):1267–73. https://doi.org/10.1038/ng.3126.

Article  PubMed  Google Scholar 

Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the hallmarks of cancer,. Cancer Cell. 2018;34(1):21–43. https://doi.org/10.1016/j.ccell.2018.03.022.

Article  PubMed  Google Scholar 

Theodore M, et al. Multiple nuclear localization signals function in the nuclear import of the transcription factor Nrf2. J Biol Chem. 2008;283(14):8984–94. https://doi.org/10.1074/jbc.M709040200.

Article  PubMed  PubMed Central  Google Scholar 

Stewart D, Killeen E, Naquin R, Alam S, Alam J. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium, (in eng). J Biol Chem. 2003;278(4):2396–402. https://doi.org/10.1074/jbc.M209195200.

Article  PubMed  Google Scholar 

Kim J, Keum YS. NRF2, a key regulator of antioxidants with two faces towards cancer, (in eng). Oxid Med Cell Longev. 2016;2016:2746457. https://doi.org/10.1155/2016/2746457.

Article  PubMed  PubMed Central  Google Scholar 

Lin M, et al. Salvianolic acid B protects against acetaminophen hepatotoxicity by inducing Nrf2 and phase II detoxification gene expression via activation of the PI3K and PKC signaling pathways, (in eng). J Pharmacol Sci. 2015;127(2):203–10. https://doi.org/10.1016/j.jphs.2014.12.010.

Article  PubMed  Google Scholar 

Horie Y, et al. Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge and Latch mechanism, (in eng). Commun Biol. 2021;4(1):576. https://doi.org/10.1038/s42003-021-02100-6.

Article  PubMed  PubMed Central  Google Scholar 

W. Fu et al., Neh1 and Neh3 domains of nuclear factor erythroid 2-related factor 2 mediate its binding to NAD-dependent protein deacetylase sirtuin-6, 2022.

Katoh Y, Itoh K, Yoshida E, Miyagishi M, Fukamizu A, Yamamoto M. Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells. 2001;6(10):857–68. https://doi.org/10.1046/j.1365-2443.2001.00469.x.

Article  PubMed  Google Scholar 

Ngo HKC, Le H, Surh YJ. Nrf2, A target for precision oncology in cancer prognosis and treatment, (in eng). J Cancer Prev. 2023;28(4):131–42. https://doi.org/10.15430/jcp.2023.28.4.131.

Article  PubMed  PubMed Central  Google Scholar 

Zhang DD, Lo SC, Sun Z, Habib GM, Lieberman MW, Hannink M. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway, (in eng). J Biol Chem. 2005;280(34):30091–9. https://doi.org/10.1074/jbc.M501279200.

Article  PubMed  Google Scholar 

Srivastava R, Fernández-Ginés R, Encinar JA, Cuadrado A, Wells G. The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance. Free Radic Biol Med. 2022;192:24660.https://doi.org/10.1016/j.freeradbiomed.2022.09.023

Article  PubMed  Google Scholar 

Panieri E, Saso L. Potential applications of NRF2 inhibitors in cancer therapy. Oxid Med Cell Longev. 2019;https://doi.org/10.1155/2019/8592348

PubMed  PubMed Central  Google Scholar 

Chauhan W, Zennadi R. Keap1-Nrf2 heterodimer: a therapeutic target to ameliorate sickle cell disease. Antioxidants. 2023;12(3):740.https://doi.org/10.3390/antiox12030740

Article  PubMed  PubMed Central  Google Scholar 

Wu J, Wang H, Tang X. Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha, (in eng). Biochem Biophys Res Commun. 2014;452(3):554–9. https://doi.org/10.1016/j.bbrc.2014.08.111.

Article  PubMed  Google Scholar 

Wang H, et al. RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2, . Cancer Res. 2013;73(10):3097–108. https://doi.org/10.1158/0008-5472.Can-12-3386.

Article  PubMed  Google Scholar 

Dayalan Naidu S, Dinkova-Kostova AT. KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease, . Open Biol. 2020;10(6):200105. https://doi.org/10.1098/rsob.200105.

Article  PubMed  PubMed Central  Google Scholar 

Lee S, Hu L. Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interaction, (in eng). Med Chem Res. 2020;29(5):846–67. https://doi.org/10.1007/s00044-020-02539-y.

Article  PubMed  PubMed Central  Google Scholar 

Ma Q. Role of nrf2 in oxidative stress and toxicity, (in eng). Annu Rev Pharmacol Toxicol. 2013;53:401–26. https://doi.org/10.1146/annurev-pharmtox-011112-140320.

Article  PubMed  PubMed Central  Google Scholar 

Abdul-Aziz A, MacEwan DJ, Bowles KM, Rushworth SA. Oxidative stress responses and NRF2 in human leukaemia. Oxid Med Cell Longev. 2015;2015(1):454659.https://doi.org/10.1155/2015/454659

PubMed  PubMed Central  Google Scholar 

Moon EJ, Giaccia A. “Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment,” (in eng). Free Radic Biol Med. 2015;79:292–9. https://doi.org/10.1016/j.freeradbiomed.2014.11.009.

Article  PubMed  Google Scholar 

Davinelli S, Medoro A, Savino R, Scapagnini G. Sleep and oxidative stress: current perspectives on the role of NRF2. Cell Mol Neurobiol. 2024;44(1):52.https://doi.org/10.1007/s10571-024-01487-0

Article  PubMed  PubMed Central  Google Scholar 

Bhat AA, et al. Nrf2 pathways in neuroprotection: alleviating mitochondrial dysfunction and cognitive impairment in aging. Life Sci. 2024. https://doi.org/10.1016/j.lfs.2024.123056.

Article  PubMed  Google Scholar